| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 529 | 4.195 | 2.791 | 3.363 | 4.647 | 8.256 | 6.540 | 5.750 | 9.789 |
| Total Income - EUR | - | 529 | 4.195 | 2.791 | 3.363 | 4.647 | 8.256 | 6.540 | 5.750 | 9.789 |
| Total Expenses - EUR | - | 10 | 34 | 28 | 427 | 462 | 904 | 758 | 1.861 | 6.688 |
| Gross Profit/Loss - EUR | - | 519 | 4.161 | 2.764 | 2.936 | 4.185 | 7.352 | 5.782 | 3.888 | 3.101 |
| Net Profit/Loss - EUR | - | 503 | 4.033 | 2.680 | 2.835 | 4.046 | 7.105 | 5.633 | 3.266 | 2.606 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Pop Irismed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 154 | 151 | 148 | 145 | 143 | 139 | 140 | 139 | 139 |
| Current Assets | - | 410 | 4.503 | 7.019 | 9.720 | 13.647 | 20.626 | 6.129 | 10.006 | 11.723 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 390 | 1.179 | 2.170 | 4.078 | 0 | 51 | 747 | 6.931 | 6.953 |
| Cash | - | 20 | 3.323 | 4.849 | 5.642 | 13.647 | 20.575 | 5.382 | 3.075 | 4.770 |
| Shareholders Funds | - | 548 | 4.572 | 7.168 | 9.864 | 13.723 | 20.523 | 5.942 | 9.190 | 11.745 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 16 | 82 | 0 | 2 | 67 | 242 | 326 | 955 | 117 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Pop Irismed Srl